Background Image
Table of Contents Table of Contents
Previous Page  16 / 64 Next Page
Information
Show Menu
Previous Page 16 / 64 Next Page
Page Background

S14

AFRICA

CVJAFRICA • Volume 26, No 2, H3Africa Supplement, March/April 2015

outcomes in the elderly.

Kidney Int

2003;

63

(3): 1121–1129.

7.

Keith DS, Nicholas GA, Gullion CM, Brown JB, Smith DH.

Longitudinal follow up and outcomes among a population with chronic

kidney disease in a large managed care organization.

Arch Intern Med

2004;

164

(6): 659–663.

8.

Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, Hruska

KA. The mechanism of phosphorus as a cardiovascular risk factor in

CKD.

J Am Soc Nephrol

2008;

19

: 1092–1105.

9.

Mann JF

,

Gerstein HC

,

Yi QL, Lonn EM

,

Hoogwerf BJ

,

Rashkow A,

et al.

Development of renal disease in people at high cardiovascular

risk: Results of the HOPE randomized study.

J Am Soc Nephrol

2003;

14

: 641–647.

10. Menon V, Sarnak MJ. The epidemiology of chronic kidney disease

stages 1 to 4 and cardiovascular disease: A high risk combination.

Am J

Kidney Dis

2005;

45

: 223–232.

11. Satko SG, Sedor JR, Iyengar SK, Freedman BI. Familial clustering of

chronic kidney disease.

Semin Dial

2007;

20

(3): 229–236.

12. Satko SG, Freedman BI, Moossavi S. Genetic factors in end-stage renal

disease.

Kidney Int Suppl

2005;

94

: S46–49.

13.

Inssera FD

G,

Alpino AMS

. Relatives of dialysis patients with increased

risk of renal failure.

Medicina

(Beunos Aires) 2007;

67

(1): 8–18.

14. Tsai JC, Chen SC, Hwang SJ, Chang JM, Lin MY, Chen HC. Prevalence

and risk factors for CKD in spouses and relatives of haemodialysis

patients.

Am J Kidney Dis

2010;

55

(3): 78–104.

15.

Wei X, Li Z

,

Chen W

,

Mao H, Li Z

,

Dong X

,

et al.

Prevalence and risk

factors of chronic kidney disease in first-degree relatives of chronic

kidney disease patients in southern, China.

Nephrol Carlton

2012;

17

(2):

123–130.

16. Salkeld G, Phongsavan P, Oldenburg B, Johannesson M, Convery P,

Graham Clarke P,

et al

. The cost-effectiveness of a cardiovascular

risk reduction program in general practice. Health policy (New York).

Ireland: Elsevier Sci Ltd, 1997;

41

(2): 105–119.

17. Brunner E, Cohen D, Toon L. Cost effectiveness of cardiovascular

disease prevention strategies: a perspective on EU food based dietary

guidelines.

Public Health Nutr

2001;

4

(2B): 711–715.

18. Chamnan P, Simmons RK, Khaw K-T, Wareham NJ, Griffin SJ.

Estimating the population impact of screening strategies for identifying

and treating people at high risk of cardiovascular disease: modelling

study.

Br Med J

2010;

340

: c1693.

19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D.

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Ann Intern Med 1999;

130

(6): 461–470.

http://www.qxmd.com/calculate-online/nephrology/mdrd-egfr. Accessed September 24

, 2014.

20. WHO guideline on prevention, detection and treatment of diabetes

mellitus, 2007.

http://www.who.int/diabetes/publications/en/

. Accessed

September 12, 2014.

21. WHO/ISH Hypertension guidelines, 2005.

http://www.who.int/cardio- vascular_diseases/guidelines/hypertension/en/.

Accessed September 12,

2014.

22. WHO | Obesity and overweight [Internet]. World Health Organisation

Media Centre fact sheet No. 311. 2012.

http://www.who.int/mediacentre/ factsheets/fs311/en

. Accessed October 18, 2014.

23. Waist circumference and waist–hip ratio. Report of a WHO expert

consultation, 2008.

http://www.who.int/nutrition/publications/obesity/ WHO_report_waistcircumference_and_waisthip_ratio/en/

. Accessed

October 18, 2014.

24. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen, W, Paccaud F,

et al

. Prevalence of hyperuricemia and relation of serum uric acid with

cardiovascular risk factors in a developing country.

BMC public Health

2004;

34

: 1473–1482.

25. Executive summary of the Third Report of the National Cholesterol

Education Program (NCEP) Expert Panel on Detection, Evaluation,

and Treatment of High Blood Cholesterol in Adults (Adult Treatment

Panel III). Expert Panel on Detection, Evaluation, and Treatment of

High Blood Cholesterol in Adults.

J Am Med Assoc

2001;

285

(19):

2486–2497.

26.

Morse RM, Flavin DK. The definition of alcoholism. The Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism. J Am Med Assoc 1992; 268 : 1012.

27. Husten CG. How should we define light or intermittent smoking? Does

it matter?

Nicotine Tob Res

2009;

11

: 111–121.

28. Oyegbade OO, Abioye-Kuteyi EA, Kolawole BA, Ezeoma IT, Bello IS.

Screening for Diabetes mellitus in a Nigerian family practice population.

SA Fam Pract

2007;

49

(8): 15–21.

29. Ogah OS, Okpechi I, Chukwuonye II, Akinyemi OJ, Onwubere BJC,

Falase AO,

et al.

Blood pressure, prevalence of hypertension and hyper-

tension related complications in Nigerian Africans: A review.

World J

Cardiol

2012;

4

(12): 327–340.

30. Mvo Z, Dick J, Steyn K. Perceptions of overweight African women

about acceptable body size of women and children.

Curationis

1999;

22

(2): 27–31.